Leptin biosynthesis in adipose cells in vivo is increased by food intake and decreased by food deprivation. However, the mechanism that couples leptin production to food intake remains unknown. We found that addition of leucine to isolated rat adipocytes significantly increased leptin production by these cells, suggesting that postprandial leptin levels may be directly regulated by dietary leucine. The effect of leucine was inhibited by rapamycin and not by actinomycin D. Besides, leucine administration did not increase the amount of leptin mRNA in adipocytes. We concluded, therefore, that leucine activates leptin expression in adipose cells at the level of translation via an mTOR (mammalian target of rapamycin)-mediated pathway. Since leptin is a secreted protein, its biosynthesis is compartmentalized on the endoplasmic reticulum. In order to analyze mTOR signaling in this subcellular fraction, we separated adipose cells by centrifugation into a heavy membrane fraction that includes virtually all endoplasmic reticulum and the cytosolic extract. Phosphorylation of the major mTOR targets, the ribosomal protein S6 and the translational inhibitor 4E-BP/PHAS-1, was stimulated by leucine in the cytosolic extract, whereas in the heavy fraction, S6 was constitutively phosphorylated and leucine only induced phosphorylation of 4E-BP/PHAS-1. We also found that 60-70% of leptin mRNA was stably associated with the heavy fraction, and leucine administration did not change the ratio between compartmentalized and free cytoplasmic leptin mRNA. We suggest that, in adipose cells, a predominant part of leptin mRNA is compartmentalized on the endoplasmic reticulum, and leucine activates translation of these messages via the mTOR/4E-BP/PHAS-1-mediated signaling pathway.
Since insulin levels respond to the nutritional status of the body, insulin itself has been suggested as a potential mediator between food intake and leptin production. (Fox et al. 1998a; Fox et al. 1998b ) and Fig. 3 ). We proposed that mTOR may be an appropriate nutrient sensor for leptin expression in adipose cells.
In agreement with this hypothesis, we found that addition of leucine to isolated rat adipocytes significantly stimulated leptin secretion in a rapamycin-sensitive and an actinomycin D-resistant fashion. Thus, dietary leucine may increase leptin production via activation of mTOR and subsequent activation of leptin mRNA translation. This mechanism may provide a long sought after connection between food intake and leptin levels in blood.
MATERIALS AND METHODS
Antibodies --Affinity purified polyclonal antibodies against phosphorylated S6 (Ser235/236), p70 S6 kinase (Thr389) and 4E-BP-1/PHAS-I (Ser65) were from Cell Signaling (Beverly, MA). Affinity purified polyclonal antibody against p70 S6 kinase was from Upstate Biotechnology (Lake Placid, NY). Polyclonal antibody against 4E-BP-1/PHAS-I was characterized earlier (Hu et al. 1994) . Affinity purified polyclonal anticalnexin antibody was from StressGen. Affinity purified polyclonal anti-calreticulin antibody was from Affinity Bioreagents (Golden, CO).
Isolation and fractionation of rat adipocytes --Adipocytes were isolated from epididymal fat pads of male Sprague-Dawley rats (Taconic, 150-175 g) by collagenase digestion (Rodbell 1964) . All animals had continuous unrestricted access to chow (TAC#31) and water. Usually, the fat pads from 8 rats were immersed in Krebs-Ringer phosphate (KRP) buffer (12.5 mM HEPES, 120 mM NaCl, 6 mM KCl, 1.2 mM MgSO 4 , 1 mM CaCl 2 , 0.6 mM Na 2 HPO 4 , 0.4 mM Na 2 PO 4 , 2.5 mM D-glucose, and 2% bovine serum albumin, pH 7.4) prepared with diethylpyrocarbonate (DEPC) treated sterile water, minced and subjected to collagenase digestion for 35 minutes at 37˚C with constant shaking at 125 cycles/minute. Under these conditions, we obtain 1 ml of adipocytes (1.8 -2.0 mg of the total protein) from 1 rat. Adipocytes were filtered through a 300 µm nylon mesh (Safar America, Depew, NY), washed three times with KRP and diluted 1:4 (v/v) with KRP. After equilibration for 20 minutes at 37˚C with constant shaking at 25 cycles/minute, cells were treated with L-leucine (Sigma, 5 mM) and transferred to the incubator with 5 % CO 2 at 37˚C for the indicated times. Cells were treated with rapamycin (Biomol, 100 nM) and actinomycin D (Sigma, 4 µM) 20 minutes prior to leucine administration until the end of the experiment. At the indicated time points, the cell medium was used for leptin analysis (see below) and the cells were washed twice with gradient buffer (100 mM KCl, 10 mM MgCl 2 , 10 mM HEPES, 1 mM EGTA, 1 mM phenylmethylsulfonyl fluoride, 1 µM pepstatin, 1 µM aprotinin, and 10 µM leupeptin, pH 7.4, 25˚C) prepared with DEPC-treated sterile water. In some experiments, phosphatase inhibitors (25 mM Na 4 P 2 O 7 , 50 mM NaF, and 5 mM Na 3 VO 4 ) or DEPC (0.01 % final concentration) together with RNAsin (Promega) were included in the buffer. After the second wash, cells in a 80-90 % suspension were centrifuged at 14,000 rpm at 4˚C for 20 minutes in a microcentrifuge. The fat layer was removed, and the supernatant and pellet were isolated for further analysis. Reverse transcriptase-polymerase chain reaction -Total RNA (4-5 µg) was reversetranscribed into cDNA using a random hexamer and reverse transcriptase. cDNA was amplified by PCR using a sense primer TGGCTTTGGTCCTATCTGTCTT, bp 87-108, and an anti-sense primer TCCTCACCAGCCTGCCTTCCC, bp 310-330 (Zhang et al. 1994) , and the PCR product was subjected to agarose gel electrophoresis. Radioimmunoassay --Leptin content was determined with a 125 I-leptin RIA kit (Linco)
Isolation of mRNA and Northern blotting --

Immunoisolation of leptin mRNP with anti-PHAS-1 antibody --
according to the manufacturer's instructions. Each sample was done in triplicates and counted for the presence of leptin in a γ-counter (Wallac).
Analysis of the secondary structure of mRNA -Secondary structure of leptin mRNA was predicted using "mfold" software by Zucker and Turner (Rensselaer Polytechnic Institute, http://bioinfo.math.rpi.edu/~mfol/rna/). Fig. 3B ). Both effects are likely to be mediated by mTOR, since addition of rapamycin completely blocks phosphorylation of these proteins. Interestingly, a leucine-induced increase in phosphorylation of 4E-BP/PHAS-1 is detectable in both the heavy fraction and cytosol. In contrast, phosphorylation of S6 in response to leucine is observed only in the cytosolic fraction. In the heavy fraction, S6 is constitutively phosphorylated irrespective of leucine treatment. These results indicate that ER-associated ribosomes that continuously synthesize secreted proteins contain phosphorylated S6. Leucine-induced activation of mTOR signaling is readily detectable even after 4 hours of incubation with leucine (Fig. 3C ). These data are consistent with the dynamics of leptin secretion (Fig. 1) , and suggest that stimulation of leptin expression by leucine requires a sustained activation of translation of leptin mRNA.
RESULTS
Fig
Activation of leptin expression at the level of translation can be accounted for by recruitment of leptin mRNA from the cytosol onto ER membranes or by activation of translation of leptin mRNA already associated with the endoplasmic reticulum. Thus, we isolated RNA separately from the heavy fraction and from cytosol of broken adipocytes and determined the levels of leptin mRNA in both fractions by Northern blot (Fig. 4) and by RT-PCR (not shown). We found that 60-70% of leptin mRNA in the cell was associated with the heavy ER-containing fraction, while 30-40% of leptin message was recovered in the cytosol where it was stored in the form of 80S mRNP particles (not shown). Leucine administration to adipocytes did not cause a significant redistribution of leptin mRNA between the cytosol and the ER-containing heavy fraction (Fig. 4A & B) .
In order to confirm this result, we performed immunoprecipitation of leptin mRNA from the cytosolic extract of adipose cells with an anti-PHAS-1 antibody. We found that leptin mRNA was specifically immunoprecipitated with this antibody but not with non-specific IgG (Fig. 5 ). This result shows that the translational repressor PHAS-1 is associated with leptin mRNA, probably, via an interaction with the cap-binding initiation factor eIF-4E. In agreement with data shown in Fig. 4 , leucine administration did not significantly change the amount of PHAS-1-associated leptin mRNA in the cytosol. Thus, correct compartmentalization of leptin mRNA in the cell may be required for its expression and regulation, as previously shown for a variety of other transcripts (Kloc et al. 2002) . We were unable to directly determine if translation of compartmentalized leptin mRNA is regulated by PHAS, because extraction of this mRNA from the heavy pellet requires high salt treatment that leads to dissociation of mRNA-binding proteins.
DISCUSSION
We show here that leptin production in isolated rat adipocytes is increased 2-3
fold by leucine within 2-4 hrs (Fig. 1) . In live rats, plasma leptin levels also rise 2. In any case, we found that the effect of leucine on leptin expression is sensitive to rapamycin and, therefore, is likely to be mediated by the mTOR pathway. This observation is consistent with several previously described effects. In particular, it has been known for several years that leptin expression in adipocytes depends on energy (Fig. 6) . Second, repressed leptin mRNA in the cytosol is associated with PHAS-1 (Fig. 5) . Third, S6 is constitutively highly phosphorylated in the ER-associated ribosomes that translate leptin mRNA, and leucine does not seem to have any additional effect on phosphorylation of S6 in this fraction (Fig. 3B ).
Approximately two thirds of leptin mRNA is associated with heavy membrane fraction and only one third is found in the cytosol in a form of 80S mRNP. We have shown that the cytosolic pool of leptin mRNA is not regulated by leucine (Figs 4 & 5) .
Thus, compartmentalization of leptin mRNA may be required for its expression and translational regulation. Based on our preliminary fractionation experiments, we suggest that, in adipocytes, the major pool of leptin mRNA is associated with the endoplasmic reticulum. Usually, intracellular localization of mRNA is defined by the 3'-UTR (Kloc et al. 2002) . Leptin mRNA has a long 3'-UTR with multiple structural elements (Zhang et al. 1994 ) that may include a localization signal. Studies are in progress to further explore specific compartmentalization of leptin mRNA in the cell.
Since insulin is known to activate the mTOR pathway in adipocytes (Lin et . We believe that a multilevel structure of leptin regulation allows for accurate adjustment of leptin secretion to match the nutritional needs of the body and for maintenance of energy homeostasis in the mammalian organism.
In particular, translational regulation of leptin mRNA by leucine via mTOR may provide a direct connection between food intake and postprandial leptin levels and thus may be essential for the formation of the satiety signal. Moreover, the involvement of mTOR in the regulation of leptin expression may help to establish a link between insulin resistance and obesity. First, normal insulin-stimulated glucose flux into adipocytes may be required for maintaining intracellular ATP levels and, hence, mTOR activity and normal leptin expression. Second, the major protein in insulin-responsive Glut4-containing vesicles is a transmembrane leucine aminopeptidase called IRAP or P-LAP (Kandror et al. 1994; Keller et al. 1995; Rogi et al. 1996) . Upon insulin administration, it is translocated to the plasma membrane and may create a pool of free leucine required for mTOR activation (Fig. 7) . This pathway could be of particular significance upon consumption of a carbohydrate-rich meal that may not sufficiently increase amino acid levels in the bloodstream. In insulin resistance, both glucose uptake and aminopeptidase translocation are impaired (Maianu et al. 2001 ). This may lead to "under-regulation" of the mTOR pathway, the uncoupling of leptin secretion from food intake, and, eventually, to obesity. Thus, in addition to its direct role in blood glucose clearance, the insulinregulated glucose transport machinery may have other regulatory functions. In particular, in fat, it may provide a feedback device that controls metabolic homeostasis in the body via mTOR-mediated production of leptin and, possibly, other secreted products (Fig. 7) . 
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